(Q46951311)

26 December 2017

title

Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease (English)

1 reference

26 December 2017

metabolic dysfunction–associated steatotic liver disease

main subject

cortisol

0 references

1 reference

Giovanni Targher

1

1 reference

26 December 2017

Lorenzo Bertolini

2

1 reference

26 December 2017

Stefano Rodella

3

1 reference

26 December 2017

Giacomo Zoppini

4

1 reference

26 December 2017

Luciano Zenari

5

1 reference

26 December 2017

Giancarlo Falezza

6

1 reference

26 December 2017

publication date

1 March 2006

1 reference

26 December 2017

published in

Clinical Endocrinology

1 reference

26 December 2017

volume

64

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

337-341

1 reference

26 December 2017

Nonalcoholic fatty liver disease

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02466.X

Recent concepts in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02466.X

Does central obesity reflect "Cushing's disease of the omentum"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02466.X

11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02466.X

A transgenic model of visceral obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02466.X

Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02466.X

Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02466.X

Relationship of nonalcoholic hepatic steatosis to overnight low-dose dexamethasone suppression test in obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02466.X

Relationship of non-alcoholic hepatic steatosis to cortisol secretion in diet-controlled Type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02466.X

Diagnosis and complications of Cushing's syndrome: a consensus statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02466.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02466.X

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02466.X

Hypothalamic origin of the metabolic syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02466.X

Neuroendocrine perturbations as a cause of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02466.X

The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02466.X

Adrenal incidentaloma: a new cause of the metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02466.X

10.1111/J.1365-2265.2006.02466.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

16487446

1 reference

26 December 2017